Regeneron Pharmaceuticals, Inc.
REGN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000872589
In the last 90 days, Regeneron Pharmaceuticals, Inc. insiders filed 0 open-market purchases and 4 sales; 1,342 institutions reported holding it in 13F filings for Q2 2026, worth $57.1B in total; Southeastern Asset Management (Longleaf) is the only superinvestor holding it.
13F holders, Q4 2025
Institutional positions in Regeneron Pharmaceuticals, Inc. as of Dec 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 1,387
- +167 vs. Q3 2025
- Shares held
- 91.6M
- +4.76M (+5.5%) vs. Q3 2025
- Total value
- $70.7B
- +$21.9B (+44.9%) vs. Q3 2025
- New holders
- 273
- 502 more added
- Sold out
- 106
- 457 more reduced
23 institutions that held it in Q3 2025 haven't filed for Q4 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting REGN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 1,342 | $57.1B |
| Q1 2026 | 1,401 | $69.8B |
| Q4 2025 | 1,387 | $70.7B |
| Q3 2025 | 1,243 | $49.0B |
| Q2 2025 | 1,201 | $46.9B |
| Q1 2025 | 1,290 | $59.0B |
| Q4 2024 | 1,320 | $66.6B |
| Q3 2024 | 1,393 | $97.5B |
| Q2 2024 | 1,335 | $98.9B |
| Q1 2024 | 1,313 | $89.3B |
| Q4 2023 | 1,274 | $80.3B |
| Q3 2023 | 1,180 | $75.1B |
| Q2 2023 | 1,168 | $66.2B |
| Q1 2023 | 1,196 | $76.1B |
| Q4 2022 | 1,161 | $66.9B |
| Q3 2022 | 1,081 | $64.0B |
| Q2 2022 | 1,066 | $55.0B |
| Q1 2022 | 1,097 | $64.5B |
| Q4 2021 | 1,081 | $56.9B |
| Q3 2021 | 1,022 | $54.5B |
| Q2 2021 | 975 | $49.6B |
| Q1 2021 | 926 | $42.3B |
Institutions, Q4 2025
Shares, value and share of portfolio for each institution holding Regeneron Pharmaceuticals, Inc.; share changes are against Q3 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Pinebridge Investments, L.P. | – | – | – | – | Not filed |
| Point72 (DIFC) Ltd | – | – | – | – | Not filed |
| Eisler Capital Management Ltd. | – | – | – | – | Not filed |
| Point72 Asia (Singapore) Pte. Ltd. | – | – | – | – | Not filed |
| Wetherby Asset Management Inc | – | – | – | – | Not filed |
| Aware Super Pty Ltd as trustee of Aware Super | – | – | – | – | Not filed |
| Synovus Financial Corp | – | – | – | – | Not filed |
| Full Sail Capital, LLC | – | – | – | – | Not filed |
| Sonora Investment Management Group, LLC | – | – | – | – | Not filed |
| Shell Asset Management Co | – | – | – | – | Not filed |
| Amica Retiree Medical Trust | – | – | – | – | Not filed |
| Hemington Wealth Management | – | – | – | – | Not filed |
| Kathleen S. Wright Associates Inc. | – | – | – | – | Not filed |
| Guerra Advisors Inc | – | – | – | – | Not filed |
| FSA Wealth Management LLC | – | – | – | – | Not filed |
| Abich Financial Wealth Management LLC | – | – | – | – | Not filed |